The Foundation and Bakar Labs will support AVECRIS Pte Ltd and Nosis Biological Sciences as they pursue genetic therapies for cystic fibrosis with their novel technologies.
Site Search
Showing 1 - 7 of 7 results
News
|
July 21, 2022
|
4 min read
This year’s awardees showcase the diversity of journeys in the cystic fibrosis community.
News
|
July 26, 2022
|
5 min read
Today, there are close to 40,000 people in the United States with CF due in large part to more people living longer into adulthood, signaling a shift in what it means to live with CF in the modern era.
News
|
July 28, 2022
|
4 min read
A transformative leader for more than two decades, Marshall will transition to advisory role
News
|
March 6, 2024
|
3 min read
The funding will help support research into the development of potential new modulator therapies for people with cystic fibrosis with an F508del mutation.
News
|
March 7, 2024
|
2 min read
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
News
|
March 18, 2024
|
2 min read
This year’s program marked the largest in-person advocacy event in the Foundation’s history.
News
|
March 19, 2024
|
3 min read